Jeffrey H. Hager

ARN-509: A Novel Antiandrogen for Prostate Cancer Treatment

Nicola J. Clegg, John Wongvipat, James D. Joseph et al. · Cancer Research · 2012 · 646 citations

Cathepsin cysteine proteases are effectors of invasive growth and angiogenesis during multistage tumorigenesis

Johanna A. Joyce, Amos Baruch, Kareem A. H. Chehade et al. · Cancer Cell · 2004 · 627 citations · Full text

Multistage Tumorigenesis, Angiogenesis, Cathepsin Cysteine Proteases +11

A Clinically Relevant Androgen Receptor Mutation Confers Resistance to Second-Generation Antiandrogens Enzalutamide and ARN-509

James D. Joseph, Nhin Lu, Jing Qian et al. · Cancer Discovery · 2013 · 570 citations · Full text

VEGF-A has a critical, nonredundant role in angiogenic switching and pancreatic β cell carcinogenesis

Masahiro Inoue, Jeffrey H. Hager, Napoleone Ferrara et al. · Cancer Cell · 2002 · 376 citations · Full text

Tumor Biology, Developmental Biology, Angiogenesis +10

Genome scanning with array CGH delineates regional alterations in mouse islet carcinomas

Graeme Hodgson, Jeffrey H. Hager, Stas Volik et al. · Nature Genetics · 2001 · 300 citations

Array Cgh, Pancreatic Cancer, Tumor Heterogeneity +9